ARCHIVES

JRB Wins $3.6 Million Support contract

This article is from The Cancer Letter archive.

Vol. 01 No. 43 | November 29, 1974

Download PDF Visit The Full Archive

Related Articles

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

In Brief: Harmon Eyre Heads Medical Affairs, Research As Third Member OF ACS National Office “Troika”

April 16, 1993

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Community Assn. Plan Meeting In DC On Program Problems

November 29, 1974